MENU
+Compare
APVO
Stock ticker: NASDAQ
AS OF
Jan 17 closing price
Price
$4.46
Change
-$0.05 (-1.11%)
Capitalization
6.5M

APVO Aptevo Therapeutics Inc Forecast, Technical & Fundamental Analysis

a provider of immunology and cancer research services

Industry Biotechnology
APVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for APVO with price predictions
Jan 08, 2025

APVO's Stochastic Oscillator soaring into overbought zone

The Stochastic Oscillator for APVO moved into overbought territory on January 08, 2025. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where APVO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 30, 2024. You may want to consider a long position or call options on APVO as a result. In of 107 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for APVO just turned positive on January 03, 2025. Looking at past instances where APVO's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where APVO advanced for three days, in of 214 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.472) is normal, around the industry mean (14.746). P/E Ratio (0.000) is within average values for comparable stocks, (88.252). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.853). APVO has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.000) is also within normal values, averaging (264.084).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. APVO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. APVO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
APVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

APVO is expected to report earnings to fall 96.35% to -43 cents per share on May 09

Aptevo Therapeutics Inc APVO Stock Earnings Reports
Q1'24
Est.
$-0.44
Q4'23
Missed
by $11.52
Q3'23
Missed
by $21.36
Q2'23
Missed
by $53.00
Q1'23
Beat
by $1.61
The last earnings report on March 06 showed earnings per share of -1193 cents, missing the estimate of -40 cents. With 43.14K shares outstanding, the current market capitalization sits at 6.50M.
A.I. Advisor
published General Information

General Information

a provider of immunology and cancer research services

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2401 4th Avenue
Phone
+1 206 838-0500
Employees
40
Web
https://www.aptevotherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNF1.180.10
+9.26%
CNFinance Holdings Limited
LEU77.833.77
+5.09%
Centrus Energy Corp
SBFM2.900.07
+2.42%
Sunshine Biopharma Inc
MPW4.090.09
+2.25%
Medical Properties Trust
LNT60.550.48
+0.80%
Alliant Energy Corp

APVO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, APVO has been loosely correlated with GOSS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if APVO jumps, then GOSS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APVO
1D Price
Change %
APVO100%
-1.11%
GOSS - APVO
42%
Loosely correlated
-3.81%
ENLV - APVO
37%
Loosely correlated
-1.74%
CYTK - APVO
36%
Loosely correlated
-2.66%
VINC - APVO
34%
Loosely correlated
+8.71%
AXON - APVO
33%
Loosely correlated
+1.37%
More